CARLSMED INC (CARL) Stock Earnings & Estimates
USA - NASDAQ:CARL - US14280C1053 - Common Stock
11.82 USD
-0.14 (-1.21%)
11.82 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.556M | 54.33M 97.16% | 47.594M -12.40% | 68.47M 43.86% | 98.535M 43.91% | 141.78M 43.89% | |
| EBITDA YoY % growth | -37.046M | -48.099M -29.84% | -29.706M 38.24% | -34.395M -15.79% | -29.137M 15.29% | -13.7M 52.98% | |
| EBIT YoY % growth | -37.182M | -48.244M -29.75% | -32.924M 31.76% | -44.639M -35.58% | -44.552M 0.19% | -34.68M 22.16% | |
| Operating Margin | -134.93% | -88.80% | -69.18% | -65.19% | -45.21% | -24.46% | |
| EPS YoY % growth | N/A | N/A | -2.72 | -1.55 43.00% | -1.50 3.25% | -1.15 23.26% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.41 | -0.42 | -0.39 |
| Revenue Q2Q % growth | 14.38M -47.06% | 14.513M 42.44% | 16.437M 36.03% |
| EBITDA Q2Q % growth | -10.125M 57.77% | -9.564M -68.41% | -9.039M -41.22% |
| EBIT Q2Q % growth | -11.202M 53.56% | -11.119M -94.43% | -11.327M -74.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.40 | -0.46 | 0.06 | 13.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.074M | 11.625M | 1.449M | 12.46% |
| Q1 2025 Q2Q % growth | 10.189M 100.33% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | -19.84% | N/A |
| Revenue | 0% | N/A | 0% | N/A |